PACTR202010472402152尚未招募未知
COVID-19 Epidemic in West Africa (WA): infection dynamics and diagnostic approaches
Medical Research Council Unit The Gambia at LSHTM0 个研究点目标入组 1,100 人开始时间: 2020年10月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 1,100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 6 Year(s) 至 12 Year(s)（—）
- 性别
- All
入选标准
- •Adults and children of both genders without age limit being either suspect of COVID-19, or contacts of a confirmed COVID-19 patient following the WHO case definitions below, are eligible to participate in the study
排除标准
- •- The subject (or parents/guardians for minors<18y) has not provided individual informed consent for the study; - The patient has already been sampled and is waiting for the results;
研究者
相似试验
进行中（未招募）
1 期
ORWEGIAN CORONAVIRUS DISEASE 2019 [NO-COVID-19] STUDY: A TRIAL TO EVALUATE THE ANTIVIRAL EFFECT OF CHLOROQUINE IN ADULT PATIENTS WITH SARS-COV-2 INFECTIOSARS-COV-2 infectionMedDRA version: 21.1Level: LLTClassification code 10037373Term: Pulmonary disorderSystem Organ Class: 100000004855EUCTR2020-001010-38-NOAkershus University Hospital200
尚未招募
Unknown
Epidemiological study on patients with COVID-19COVID-19JPRN-UMIN000050989The Jikei University School of Medicine, Japan2,000
招募中
不适用
BREAK COVID: COVID-19 breakthrough infections and correlates of protectiocoronavirusCOVID-1910047438NL-OMON53358eids Universitair Medisch Centrum550
招募中
不适用
Reserch on patients with COVID-19 at Osaka Saiseikai Nakatsu HospitalCOVID-19JPRN-UMIN000041102Osaka Saiseikai Nakatsu Hospital1,200
已完成
1 期
Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-EBOMAB092-00-AB (MAb114), Administered Intravenously to Healthy AdultsHealthy Adult Immune Responses to VaccineNCT03478891National Institute of Allergy and Infectious Diseases (NIAID)19